These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8797624)

  • 1. Comparison of early and late treatment with a recombinant endotoxin neutralizing protein in a rat model of Escherichia coli sepsis.
    Weiner DL; Kuppermann N; Saladino RA; Thompson CM; Novitsky TJ; Siber GR; Fleisher GR
    Crit Care Med; 1996 Sep; 24(9):1514-7. PubMed ID: 8797624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose recombinant endotoxin neutralizing protein improves survival in rabbits, with Escherichia coli sepsis.
    Saladino RA; Stack AM; Thompson C; Sattler F; Novitsky TJ; Siber GR; Fleisher GR
    Crit Care Med; 1996 Jul; 24(7):1203-7. PubMed ID: 8674336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats.
    Nelson D; Kuppermann N; Fleisher GR; Hammer BK; Thompson CM; Garcia CT; Novitsky TJ; Parsonnet J; Onderdonk A; Siber GR
    Crit Care Med; 1995 Jan; 23(1):92-8. PubMed ID: 8001394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a recombinant endotoxin-neutralizing protein with a human monoclonal antibody to endotoxin for the treatment of Escherichia coli sepsis in rats.
    Kuppermann N; Nelson DS; Saladino RA; Thompson CM; Sattler F; Novitsky TJ; Fleisher GR; Siber GR
    J Infect Dis; 1994 Sep; 170(3):630-5. PubMed ID: 8077721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of bactericidal/permeability-increasing protein variant versus recombinant endotoxin-neutralizing protein for the treatment of Escherichia coli sepsis in rats .
    Stack AM; Saladino RA; Siber GR; Thompson C; Marra MN; Novitsky TJ; Fleisher GR
    Crit Care Med; 1997 Jan; 25(1):101-5. PubMed ID: 8989184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a recombinant endotoxin neutralizing protein in rabbits with Escherichia coli sepsis.
    Saladino R; Garcia C; Thompson C; Hammer B; Parsonnet J; Novitsky T; Siber G; Fleisher G
    Circ Shock; 1994 Feb; 42(2):104-10. PubMed ID: 8013061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits.
    Garcia C; Saladino R; Thompson C; Hammer B; Parsonnet J; Wainwright N; Novitsky T; Fleisher GR; Siber G
    Crit Care Med; 1994 Aug; 22(8):1211-8. PubMed ID: 8045139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit.
    Stack AM; Saladino RA; Thompson C; Sattler F; Weiner DL; Parsonnet J; Nariuchi H; Siber GR; Fleisher GR
    Crit Care Med; 1995 Sep; 23(9):1512-8. PubMed ID: 7664553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of different classes antimicrobial agents on plasma endotoxin activity.
    Nitsche D; Schulze C; Oesser S; Dalhoff A; Sack M
    Arch Surg; 1996 Feb; 131(2):192-9. PubMed ID: 8611078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis.
    Shenep JL; Barton RP; Mogan KA
    J Infect Dis; 1985 Jun; 151(6):1012-8. PubMed ID: 3889171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
    Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; D'Amato G; Orlando F; Sisti V; Kamysz W; Silvestri C; Naldoski P; Lukasiak J; Saba V; Scalise G
    J Antimicrob Chemother; 2004 Sep; 54(3):654-60. PubMed ID: 15294887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of Endotoxin, Inflammatory Variables, and Organ Dysfunction After Treatment With Antibiotics in an Escherichia coli Porcine Intensive Care Sepsis Model.
    Skorup P; Maudsdotter L; Tano E; Lipcsey M; Castegren M; Larsson A; Sjölin J
    Crit Care Med; 2018 Jul; 46(7):e634-e641. PubMed ID: 29595561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dantrolene, an inhibitor of intracellular calcium release, fails to increase survival in a rat model of intra-abdominal sepsis.
    Cameron EM; Zhuang J; Menconi MJ; Phipps R; Fink MP
    Crit Care Med; 1996 Sep; 24(9):1537-42. PubMed ID: 8797628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphibian peptides prevent endotoxemia and bacterial translocation in bile duct-ligated rats.
    Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Silvestri C; Orlando F; Kamysz W; Licci A; Kamysz E; Lukasiak J; Saba V; Scalise G
    Crit Care Med; 2006 Sep; 34(9):2415-20. PubMed ID: 16791114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limulus antilipopolysaccharide factor prevents mortality late in the course of endotoxemia.
    Roth RI; Su D; Child AH; Wainwright NR; Levin J
    J Infect Dis; 1998 Feb; 177(2):388-94. PubMed ID: 9466526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats.
    Lundblad R; Nesland JM; Giercksky KE
    Crit Care Med; 1996 May; 24(5):820-6. PubMed ID: 8706460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis.
    Cirioni O; Ghiselli R; Silvestri C; Kamysz W; Orlando F; Riva A; Kamysz E; Castelletti S; Rocchi M; Saba V; Scalise G; Giacometti A
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4351-5. PubMed ID: 18779356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
    Taylor FB; Wada H; Kinasewitz G
    Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antibiotics on gram-negative sepsis in the rat. Lack of endotoxin burst.
    Almdahl SM; Osterud B
    Acta Chir Scand; 1987 Apr; 153(4):283-6. PubMed ID: 3307255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia.
    Opal SM; Palardy JE; Parejo N; Jasman RL
    Crit Care Med; 2003 Mar; 31(3):929-32. PubMed ID: 12627007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.